Search results for "ANTIBIOTICS"

showing 10 items of 472 documents

Optimal treatment of leptospirosis: queries and projections.

2006

Although the global burden of leptospirosis remains enormous and new aspects of the disease are constantly recognised, little progress has been achieved in the field of leptospirosis therapeutics and queries regarding the utility of antibiotics in the late severe form of the disease remain. From the currently existing data, conclusions on the efficacy of antibiotic administration in severe or late disease cannot easily be drawn, since clinical trials have different selection criteria and may focus on Leptospira serovars with different virulence. However, as a rule the benefit of the doubt should apply. Moreover, new options, such as ceftriaxone, have a superior safety profile to penicillin.…

Microbiology (medical)medicine.medical_specialtymedicine.drug_classAntibioticsDiseaseLeptospirosiMiceLeptospiramedicineAnimalsHumansPharmacology (medical)LeptospirosisIntensive care medicineAntibacterial agentLeptospirabiologybusiness.industryOptimal treatmentCeftriaxoneGeneral Medicinemedicine.diseasebiology.organism_classificationPenicillinLeptospirosisAnti-Bacterial AgentsClinical trialTreatmentSafety profileInfectious DiseasesDoxycyclineImmunologybusinessInternational journal of antimicrobial agents
researchProduct

Role of D-Mannose in the Prevention of Recurrent Uncomplicated Cystitis: State of the Art and Future Perspectives

2021

Background: Urinary tract infections (UTI) are highly frequent in women, with a significant impact on healthcare resources. Although antibiotics still represent the standard treatment to manage recurrent UTI (rUTI), D-mannose, an inert monosaccharide that is metabolized and excreted in urine and acts by inhibiting bacterial adhesion to the urothelium, represents a promising nonantibiotic prevention strategy. The aim of this narrative review is to critically analyze clinical studies reporting data concerning the efficacy and safety of D-mannose in the management of rUTIs. Methods: A non-systematic literature search, using the Pubmed, EMBASE, Scopus, Web of science, Cochrane Central Register …

Microbiology (medical)medicine.medical_specialtymedicine.drug_classUTIAntibiotics030232 urology & nephrologyReviewPlaceboBiochemistryMicrobiologylaw.invention03 medical and health sciences0302 clinical medicineRandomized controlled trialpreventionlawInternal medicineMedicinePharmacology (medical)General Pharmacology Toxicology and PharmaceuticsMedical prescriptionProspective cohort studyAdverse effectcystitistreatmentbusiness.industryStandard treatmentlcsh:RM1-950Infectious DiseasesSystematic reviewlcsh:Therapeutics. Pharmacologyfemale030220 oncology & carcinogenesiscystitis; d-mannose; female; prevention; treatment; urinary tract infections; utiurinary tract infectionsbusinessD-mannoseAntibiotics
researchProduct

Regulatory and metabolic proteins differentially expressed during NAI-107 production in Microbispora sp. ATCC-PTA 5024

2014

Microbispora sp. ATCC-PTA 5024proteomicsNAI-107NAI-107 LantibioticsMicrobispora sp. ATCC-PTA 5024 proteomicsLantibiotics
researchProduct

Documento de consenso sobre el tratamiento antimicrobiano de las infecciones bacterianas odontogénicas

2005

Las infecciones de la cavidad bucal son un problema de salud pública frecuente y motivo constante de prescripción antibiótica; el 10% de los antibióticos se emplean para tratar este problema. Sin embargo, hasta la fecha son pocos los estudios realizados para determinar su incidencia. Asímismo, su relación con ciertas enfermedades sistémicas (cardiacas, endocrinas, etc...) confiere a estas patologías una importancia vital. A pesar de la reconocida frecuencia e importancia de las infecciones odontogénicas, llama la atención la actual dispersión de criterio en varios aspectos referentes a su clasificación, terminología y recomendaciones terapéuticas. El objetivo principal de este documento, re…

MicroorganismosEfecte dels medicaments sobre els microorganismes:CIENCIAS MÉDICAS ::Ciencias clínicas::Otras [UNESCO]Bacterial diseasesMicroorganismsAntibiòticsOral medicineMicroorganismesMouth MicrobiologyClasificaciónMalalties de la bocaInfectionsAmoxicilina/ácido clavulánicoAntibioticsResistenciaTratamientoMicrobiologia dentalOdontogénicosAntibióticosInfecciones odontogénicas; Clasificación; Diagnóstico; Tratamiento; Microorganismos; Odontogénicos; Resistencia; Antimicrobianos; Antibióticos; Amoxicilina/ácido clavulánicoGeneral DentistryAntimicrobianosMouthMalalties bacterianesUNESCO::CIENCIAS MÉDICAS ::Ciencias clínicas::OtrasBocaDiagnósticoInfecciones odontogénicasInfeccionsMouth diseasesOtorhinolaryngologyEstomatologiaEffect of drugs on microorganisms
researchProduct

Isolation and Characterization of Two Klebsiella pneumoniae Phages Encoding Divergent Depolymerases

2020

The emergence of multidrug-resistant bacteria is a major global health concern. The search for new therapies has brought bacteriophages into the spotlight, and new phages are being described as possible therapeutic agents. Among the bacteria that are most extensively resistant to current antibiotics is Klebsiella pneumoniae, whose hypervariable extracellular capsule makes treatment particularly difficult. Here, we describe two new K. pneumoniae phages, &pi

Models Molecular0301 basic medicineKlebsiellaPhage therapyKlebsiella pneumoniae<i>Klebsiella pneumoniae</i>virusesmedicine.medical_treatmentAntibioticsMolecular Conformationlcsh:ChemistryBacteriophagebacteriophagewide infection rangeBacteriophagesAntigens Virallcsh:QH301-705.5PhylogenySpectroscopybiologyGeneral Medicine3. Good healthComputer Science ApplicationsKlebsiella pneumoniaePhenotypephage therapyPhage therapymedicine.drug_class030106 microbiologyGenome ViralArticleHost SpecificityCatalysisMicrobiologyInorganic ChemistryViral Proteins03 medical and health sciencesPodoviridaeBacteriolysismedicineAmino Acid SequencePhysical and Theoretical ChemistryBacteriophageMolecular BiologyTropismWhole Genome SequencingOrganic ChemistryComputational BiologyGenetic VariationMolecular Sequence Annotationbiology.organism_classificationKlebsiella Infections030104 developmental biologylcsh:Biology (General)lcsh:QD1-999Wide infection rangeBacteriaInternational Journal of Molecular Sciences
researchProduct

Intercalation of daunomycin into stacked DNA base pairs. DFT study of an anticancer drug

2008

We have computationally studied the intercalation of the antitumor drug daunomycin into six stacks of Watson-Crick DNA base pairs i.e., AT-AT, AT-TA, GC-AT, CG-TA, GC-GC, GC-CG) using density functional theory (DFT). The proton affinity of the DNA intercalater daunomycin in water was computed to be 159.2 kcal/mol at BP86/TZ2P, which is in line with the experimental observation that daunomycin is protonated under physiological conditions. The intercalation interaction of protonated daunomycin with two stacked DNA base pairs was studied through a hybrid approach in which intercalation is treated at LDA/TZP while the molecular structure of daunomycin and hydrogen-bonded Watson-Crick pairs is c…

Models MolecularBase pairStereochemistryIntercalation (chemistry)Stacking/dk/atira/pure/sustainabledevelopmentgoals/clean_water_and_sanitationNucleobaseSDG 3 - Good Health and Well-beingStructural BiologyIntercalationMoleculeBase PairingMolecular BiologyAntibiotics AntineoplasticHydrogen bondChemistryDaunorubicinWaterHydrogen BondingDaunomycinDNAGeneral MedicineStacking interactionsSettore CHIM/08 - Chimica FarmaceuticaIntercalating AgentsNucleobaseCrystallographyModels ChemicalSettore CHIM/03 - Chimica Generale E Inorganica/dk/atira/pure/sustainabledevelopmentgoals/good_health_and_well_beingNucleic Acid ConformationThermodynamicsProton affinityDensity functional theoryBond energyDensity functional calculationSDG 6 - Clean Water and Sanitation
researchProduct

An Experimental Toolbox for Structure‐Based Hit Discovery for P. aeruginosa FabF, a Promising Target for Antibiotics

2021

Abstract FabF (3‐oxoacyl‐[acyl‐carrier‐protein] synthase 2), which catalyses the rate limiting condensation reaction in the fatty acid synthesis II pathway, is an attractive target for new antibiotics. Here, we focus on FabF from P. aeruginosa (PaFabF) as antibiotics against this pathogen are urgently needed. To facilitate exploration of this target we have set up an experimental toolbox consisting of binding assays using bio‐layer interferometry (BLI) as well as saturation transfer difference (STD) and WaterLOGSY NMR in addition to robust conditions for structure determination. The suitability of the toolbox to support structure‐based design of FabF inhibitors was demonstrated through the …

Models MolecularBio-layer interferometrymedicine.drug_classAntibioticsMicrobial Sensitivity TestsCrystallography X-RayLigandsBiochemistryantibiotics3-Oxoacyl-(Acyl-Carrier-Protein) SynthaseDrug Discoverymedicinebio-layer interferometryGeneral Pharmacology Toxicology and PharmaceuticsEnzyme InhibitorsPharmacologyligand-based NMRVirtual screeningBiological ProductsFull PaperMolecular StructureChemistryOrganic ChemistryLimitingFull Papersvirtual screeningCombinatorial chemistrystructure-based designAnti-Bacterial AgentsSaturation transferPseudomonas aeruginosaMolecular MedicineStructure basedChemmedchem
researchProduct

Self-assembly of janus dendrimers into uniform dendrimersomes and other complex architectures

2010

Janus Drug Delivery Vehicle Efficient drug delivery vehicles need to be produced in a limited size range and with uniform size distribution. The self-assembly of traditional small-molecule and polymeric amphiphiles has led to the production of micelles, liposomes, polymeric micelles, and polymersomes for use in drug delivery applications. Now, Percec et al. (p. 1009 ) describe the self-assembly of Janus-type (i.e., two-headed) dendrimers to produce monodisperse supramolecular constructs, termed “dendrimersomes,” and other complex architectures. The structures, which showed long-term stability as well as very narrow size distributions, were easily produced by the injection of an ethanolic so…

Models MolecularDendrimersMaterials scienceSurface Propertiesta221Complex ArchitecturesNanotechnologyMolecular Dynamics SimulationSurface-Active AgentsBiomimetic MaterialsDendrimerAmphiphileJanusta218LiposomeDrug Carriersta214MultidisciplinaryAntibiotics Antineoplasticta114Molecular StructureVesicleCryoelectron MicroscopyWaterMembranes ArtificialNanostructuresJanus DendrimersSelf-AssemblyMembraneUniform DendrimersomesDoxorubicinPolymersomeSelf-assemblyHydrophobic and Hydrophilic InteractionsScience
researchProduct

New potent antibacterials against Gram-positive multiresistant pathogens: effects of side chain modification and chirality in linezolid-like 1,2,4-ox…

2014

The effects of side chain modification and chirality in linezolid-like 1,2,4-oxadiazoles have been studied to design new potent antibacterials against Gram-positive multidrug-resistant pathogens. The adopted strategy involved a molecular modelling approach, the synthesis and biological evaluation of new designed compounds, enantiomers separation and absolute configuration assignment. Experimental determination of the antibacterial activity of the designed (S)-1-((3-(4-(3-methyl-1,2,4-oxadiazol-5- yl)phenyl)-oxazolidin-2-one-5-yl)methyl)-3-methylthiourea and (S)-1-((3-(3-fluoro-4-(3-methyl-1,2,4- oxadiazol-5-yl)phenyl)-oxazolidin-2-one-5-yl)methyl)-3-methylthiourea against multidrug resistan…

Multidrug-resistant bacteriaClinical BiochemistryAntibioticsDrug ResistanceMolecular ConformationPharmaceutical ScienceBiochemistrychemistry.chemical_compoundAntibioticsDrug Resistance Multiple BacterialDrug DiscoveryAcetamidesSide chainOxadiazolesAbsolute configurationBacterialStereoisomerismHep G2 CellsBIO/10 - BIOCHIMICA23SAnti-Bacterial AgentsMolecular Docking SimulationRNA Ribosomal 23SDrug design Linezolid Antibiotics Multidrug-resistant bacteria EnantiomersMolecular MedicineAntibacterial activityMultipleMethicillin-Resistant Staphylococcus aureusStaphylococcus aureusmedicine.drug_classStereochemistryCell SurvivalMicrobial Sensitivity TestsGram-Positive BacteriaDrug designmedicineHumansMolecular BiologyOxazolidinonesRibosomalBinding SitesOrganic ChemistryAntibioticLinezolidSettore CHIM/06 - Chimica OrganicaSettore CHIM/08 - Chimica FarmaceuticaMultiple drug resistancechemistryEnantiomersMED/07 - MICROBIOLOGIA E MICROBIOLOGIA CLINICALinezolidRNANucleic Acid ConformationEnantiomerChirality (chemistry)Bioorganicmedicinal chemistry
researchProduct

Estimation of the Amount of Disposed Antibiotics

2019

The impact of the antibiotics in the environment is not well understood yet. Moreover, the total amount of antibiotics that are ending up in the environment as solid waste is not known and cannot be rigorously determined as many variables are influencing the determination of their concentration. The present article is focused on the estimation of the amount of non-prescribed antibiotics that are used in different European countries. Particular attention is paid to the class of beta-lactams, as they are responsible for a considerate share of the antimicrobial resistance. The primary purpose was the estimation of the quantity of non-prescribed antibiotics that might reach the environment as s…

Municipal solid wastemedicine.drug_classGeography Planning and DevelopmentAntibioticsTJ807-830010501 environmental sciencesManagement Monitoring Policy and LawTD194-19501 natural sciencesantibiotics disposalRenewable energy sources03 medical and health sciencesAntibiotic resistancemedicineGE1-3500105 earth and related environmental sciencesEstimation0303 health sciencesEnvironmental effects of industries and plants030306 microbiologyRenewable Energy Sustainability and the Environmentbusiness.industryBiotechnologyEnvironmental sciencessolid-wastebusinessnon-prescribed antibioticsSustainability
researchProduct